Evidence map›Paper›PMID 29636417›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Crystal structure and mechanism of human carboxypeptidase O: Insights into its specific activity for acidic residues.

Maria C Garcia-Guerrero, Javier Garcia-Pardo, Esther Berenguer, Roberto Fernandez-Alvarez, Gifty B Barfi, Peter J Lyons, Francesc X Aviles, Robert Huber, Julia Lorenzo, David Reverter

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Structure ofLife science alliance · 2022
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Maria C Garcia-GuerreroInstitute for Biotechnology and Biomedicine, Universitat Autonoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.
Javier Garcia-PardoInstitute for Biotechnology and Biomedicine, Universitat Autonoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.ORCID 0000-0001-9179-6371
Esther BerenguerInstitute for Biotechnology and Biomedicine, Universitat Autonoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.
Roberto Fernandez-AlvarezInstitute for Biotechnology and Biomedicine, Universitat Autonoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.
Gifty B BarfiDepartment of Biology, Andrews University, Berrien Springs, MI 49104.
Peter J LyonsDepartment of Biology, Andrews University, Berrien Springs, MI 49104.
Francesc X AvilesInstitute for Biotechnology and Biomedicine, Universitat Autonoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.
Robert HuberMax Planck Institut für Biochemie, D-82152 Martinsried, Germany; huber@biochem.mpg.de julia.lorenzo@uab.cat David.Reverter@uab.cat.
Julia LorenzoInstitute for Biotechnology and Biomedicine, Universitat Autonoma de Barcelona, 08193 Bellaterra, Barcelona, Spain; huber@biochem.mpg.de julia.lorenzo@uab.cat David.Reverter@uab.cat.
David ReverterInstitute for Biotechnology and Biomedicine, Universitat Autonoma de Barcelona, 08193 Bellaterra, Barcelona, Spain; huber@biochem.mpg.de julia.lorenzo@uab.cat David.Reverter@uab.cat.
Universitat Autònoma de Barcelona · ESAndrews University · USMax Planck Institute of Biochemistry · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human metallocarboxypeptidase O (hCPO) is a recently discovered digestive enzyme localized to the apical membrane of intestinal epithelial cells. Unlike pancreatic metallocarboxypeptidases, hCPO is glycosylated and produced as an active enzyme with distinctive substrate specificity toward C-terminal (C-t) acidic residues. Here we present the crystal structure of hCPO at 1.85-Å resolution, both alone and in complex with a carboxypeptidase inhibitor (NvCI) from the marine snail

Indexed as

CarboxypeptidasesCatalytic DomainCrystallography, X-RayHumansPancreasProtease InhibitorsSubstrate SpecificityCarboxypeptidasesProtease Inhibitorsacidic proteasecarboxypeptidasecrystal structureprotein digestion

Identifiers

PMID29636417
PMCPMC5924935
OpenAlexW2797736339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.